Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Activation in HIV-1 Infected Patients (ACTIVIH)
NCT02334943Completed
- Sponsor
- CHU Montpellier
- Start
- Mar 2015
- Primary completion
- Mar 2015
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by CHU Montpellier. Primary endpoint: Infection of novo persistent. Started Mar 2015; status: completed.
Beyond the preview
Go deeper on NCT02334943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02334943.